Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novo CEO to depart as obesity drugmaker’s challenges rise
BioPharma Dive
Friday, May 16, 2025 - 11:47am
tags:
Novo Nordisk, Pharma CEOs, Lars Jørgensen
BioMarin Expands Enzyme Expertise With $270M Inozyme Buy
BioSpace
Friday, May 16, 2025 - 11:45am
tags:
Biomarin, M&A, Inozyme, INZ-701, Rare Diseases
Dexcom CEO says CGMs fit MAHA agenda ‘very nicely’; Tandem preps for new products
Medtech Dive
Friday, May 16, 2025 - 11:43am
tags:
DexCom, Medtech, CGMs, type 2 diabetes, diabetes, PBMs, G7
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Fierce Pharma
Friday, May 16, 2025 - 11:40am
tags:
Amgen, Regeneron, PCSK9, legal, antitrust, Praluent, Repatha
A Fierce breakdown of the 'most favored nation' executive order
Fierce Pharma
Friday, May 16, 2025 - 11:38am
tags:
Donald Trump, drug pricing, most favored nation
RFK Jr's HHS to end routine COVID vaccine guidance for children, pregnant women: report
FOX News
Friday, May 16, 2025 - 11:37am
tags:
vaccines, COVID-19, CDC, HHS, Robert F Kennedy Jr.
Bristol Myers Squibb (BMY) CEO Calls for Fair Global Drug Pricing
Guru Focus
Friday, May 16, 2025 - 11:32am
tags:
Bristol Myers Squibb, Pharma CEOs, Chris Boerner, Donald Trump, drug pricing
Saving pediatric cancer drugs from the ‘valley of death’
Beckers Hospital Review
Friday, May 16, 2025 - 11:23am
tags:
cancer, pediatric, oncology, drug development
Abbott’s studies show CGM technology linked to lower heart hospitalisation risk
Clinical Trials Arena
Friday, May 16, 2025 - 11:20am
tags:
Medtech, Abbott Labs, CGMs, FreeStyle Libre, type 1 diabetes
Incyte's PD-1 drug brings immunotherapy to anal cancer
Pharmaphorum
Friday, May 16, 2025 - 11:16am
tags:
Incyte, Zynyz, anal cancer, FDA
After FDA Cuts, Planning for Upcoming ODAC Meeting Has Been ‘Absolute Chaos’
BioSpace
Thursday, May 15, 2025 - 10:48pm
tags:
FDA, ODAC, layoffs
CVS Bids for Rite Aid Stores, Patient Files in Pacific Northwest
Yahoo/Bloomberg
Thursday, May 15, 2025 - 10:43pm
tags:
CVS Health, Rite Aid, pharmacies, M&A
Eli Lilly Collaborates With Rznomics On Hearing Loss Treatment In $1.3 Billion Pact
Benzinga
Thursday, May 15, 2025 - 10:40pm
tags:
Eli Lilly, Rznomics, hearing loss, RNA therapeutics
Eisai Projects Significant Growth for Alzheimer’s Drug Leqembi
Tip Ranks
Thursday, May 15, 2025 - 10:31pm
tags:
Eisai, Alzheimer's disease, Leqembi
Merck's Keytruda finds a path in ovarian cancer with phase 3 win in certain recurrent patients
Fierce Pharma
Thursday, May 15, 2025 - 10:25pm
tags:
Merck, Keytruda, ovarian cancer, clinical trials
FDA approves Amneal's self-administered migraine treatment
MSN/Reuters
Thursday, May 15, 2025 - 11:23am
tags:
Amneal Pharmaceuticals, migraines, Brekiya, FDA, autoinjectors
Arcturus stops work on early-stage vaccine programs in effort to 'streamline resources'
Fierce Biotech
Thursday, May 15, 2025 - 11:17am
tags:
Arcturus Therapeutics, MRNA, vaccines
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Fierce Biotech
Thursday, May 15, 2025 - 11:08am
tags:
New Jersey, biotech hubs, incubators, biotech, venture capital, Portal Innovations
Philips taps Nvidia to build AI model for MRI
Medtech Dive
Thursday, May 15, 2025 - 11:06am
tags:
Medtech, Philips, NVIDIA, MRI, artificial intelligence
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
Fierce Biotech
Thursday, May 15, 2025 - 11:02am
tags:
Biohaven, FDA, troriluzole, adcomm, Rare Diseases

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.